Literature DB >> 12173113

Outcomes of improved anaerobic techniques in clinical microbiology.

Joan Barenfanger1, Cheryl A Drake, Jerry Lawhorn, Carla Kopec, Robbin Killiam.   

Abstract

To our knowledge, the effects of the use of improved anaerobic techniques have not been documented. We compared data on patients during 2 different time periods-the first when anaerobic cultures were done by standard techniques (the control or "before" group) and the second when anaerobic cultures were done after an intensive program to improve anaerobic techniques (IAT). The program consisted of the use of an anaerobe chamber, improved anaerobic transport and media, and education of clinicians and microbiologists. There were 74 diagnosis-related group (DRG)-matched patients in the controls and 76 in the IAT group. The average turnaround time for preliminary anaerobic data was decreased in the IAT group (124 hours per specimen for controls and 107 for IAT, P=.001). The cost of achieving anaerobic conditions for a plate was approximately $0.09 when the anaerobic chamber was used and $0.96 when the bio-bag system was used. The crude mortality rate was 10.8% in controls and 1.3% in the IAT group (P=.06). The average length of stay was 10.2 days per patient in controls and 8.9 in the IAT group (P=.91). The average variable cost was $6865 per patient in the control group and $4432 in the IAT group (P=.21). The average laboratory cost was $723 per patient in the control group and $380 in the IAT group (P=.08). In conclusion, benefits associated with improved anaerobic testing were documented. We could expect to save >$630,000 every year with improved anaerobic processes.

Entities:  

Mesh:

Year:  2002        PMID: 12173113     DOI: 10.1086/341925

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Dynamic imaging of autophagy-lysosomal pathway and autophagy function following pulmonary hypoxia/reoxygenation in vitro.

Authors:  Tian-Shu Liu; Yi-Ting Cai; Zhi-Fu Mao; Jie Huang; Tao Fan; Qing Geng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  The value of outcomes data in the practice of clinical microbiology.

Authors:  Gary V Doern
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

Review 3.  The Microbiome and Chronic Rhinosinusitis.

Authors:  Do-Yeon Cho; Ryan C Hunter; Vijay R Ramakrishnan
Journal:  Immunol Allergy Clin North Am       Date:  2020-01-16       Impact factor: 3.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.